[Locoregional interferon therapy in urology].
Review of loco-regional application of interferon (IFN) in the treatment of urological tumors. Only in the recurrence prophylaxis of superficial bladder cancer promising results of phase II studies are available. So an ongoing study of the Austrian Urology Oncology group (AUO). In general locoregional IFN application in the treatment of urological tumors should be restricted to clinical trials.
Studler
G
G
Urologische Abteilung, Sozialmedizinischen Zentrums Ost der Stadt Wien-Donauspital.
D000283:Administration, Intravesical; D017322:Clinical Trials, Phase II as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D014565:Urogenital Neoplasms / Q000628:therapy*
D016898:Interferon-alpha
Lokoregionale Interferontherapie in der Urologie.